Free Trial

Nektar Therapeutics (NKTR) Short Interest Ratio & Short Volume

Nektar Therapeutics logo
$1.00 -0.03 (-2.91%)
(As of 11/20/2024 ET)

Nektar Therapeutics Short Interest Data

Nektar Therapeutics (NKTR) has a short interest of 5.23 million shares, representing 2.94% of the float (the number of shares available for trading by the public). This marks a -13.41% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 1.80 million shares to cover all short positions.

Current Short Interest
5,230,000 shares
Previous Short Interest
6,040,000 shares
Change Vs. Previous Month
-13.41%
Dollar Volume Sold Short
$6.22 million
Short Interest Ratio
4.4 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
184,460,000 shares
Float Size
177,810,000 shares
Short Percent of Float
2.94%
Today's Trading Volume
1,485,696 shares
Average Trading Volume
1,798,017 shares
Today's Volume Vs. Average
83%
Short Selling Nektar Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Nektar Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NKTR Short Interest Over Time

NKTR Days to Cover Over Time

NKTR Percentage of Float Shorted Over Time

Nektar Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20245,230,000 shares $6.22 million -13.4%2.9%4.4 $1.19
10/15/20246,040,000 shares $7.79 million -17.4%3.4%5.9 $1.29
9/30/20247,310,000 shares $9.50 million -5.8%4.1%7.1 $1.30
9/15/20247,760,000 shares $10.17 million -5.8%4.4%5.2 $1.31
8/31/20248,240,000 shares $10.55 million -2.7%4.6%5.2 $1.28
8/15/20248,470,000 shares $10.08 million -4.1%4.8%4.9 $1.19
7/31/20248,830,000 shares $11.83 million -9.2%4.9%4.7 $1.34
7/15/20249,720,000 shares $13.61 million +140.0%5.4%5 $1.40
6/30/20244,050,000 shares $5.02 million -6.7%2.3%1.7 $1.24
6/15/20244,340,000 shares $5.08 million +58.4%2.4%1.9 $1.17
5/31/20242,740,000 shares $3.48 million +3.4%1.5%1.3 $1.27
5/15/20242,650,000 shares $4.85 million -25.1%1.5%1 $1.83
4/30/20243,540,000 shares $5.17 million +13.8%2.0%1.4 $1.46
4/15/20243,110,000 shares $4.88 million +31.8%1.8%1.3 $1.57
3/31/20242,360,000 shares $2.20 million -6.0%1.3%1.2 $0.93
3/15/20242,510,000 shares $2.16 million +24.9%1.4%1.6 $0.86
2/29/20242,010,000 shares $1.43 million -18.0%1.1%1.2 $0.71
2/15/20242,450,000 shares $1.81 million -57.8%N/A2 $0.74
1/31/20245,800,000 shares $3.15 million +6.6%N/A4.8 $0.54
1/15/20245,440,000 shares $2.91 million +1.7%N/A3.7 $0.53
12/31/20235,350,000 shares $3.02 million -23.1%N/A3.4 $0.57
12/15/20236,960,000 shares $3.26 million -3.7%N/A4.5 $0.47
11/30/20237,230,000 shares $3.54 million -9.7%N/A4.6 $0.49
11/15/20238,010,000 shares $4.21 million +7.2%N/A4.7 $0.53
10/31/20237,470,000 shares $3.50 million -8.8%N/A2.8 $0.47
10/15/20238,190,000 shares $4.41 million +5.8%N/A1.4 $0.54
9/30/20237,740,000 shares $4.61 million +6.6%N/A1.3 $0.60
9/15/20237,260,000 shares $5.12 million +7.1%N/A1.2 $0.71
8/31/20236,780,000 shares $4.03 million -5.2%N/A1 $0.60
8/15/20237,150,000 shares $5.79 million +23.3%N/A1 $0.81
7/31/20235,800,000 shares $3.11 million +9.9%N/A0.9 $0.54
7/15/20235,280,000 shares $2.90 million -2.8%N/A1.5 $0.55
6/30/20235,430,000 shares $3.12 million -50.8%N/A1.4 $0.58
6/15/202311,030,000 shares $6.23 million +11.5%N/A2 $0.56
5/31/20239,890,000 shares $5.74 million -2.1%N/A2 $0.58
5/15/202310,100,000 shares $7.71 million +5.4%N/A2 $0.76
4/30/20239,580,000 shares $7.21 million +16.7%5.8%2 $0.75
4/15/20238,210,000 shares $7.60 million -3.5%N/A1.7 $0.93
3/31/20238,510,000 shares $5.98 million +20.2%N/A1.9 $0.70
3/15/20237,080,000 shares $8.07 million -19.1%N/A2.9 $1.14
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

2/28/20238,750,000 shares $12.08 million -11.8%N/A4.5 $1.38
2/15/20239,920,000 shares $30.85 million -0.1%N/A4.9 $3.11
1/31/20239,930,000 shares $27.01 million +7.7%N/A6.1 $2.72
1/15/20239,220,000 shares $23.23 million +2.4%N/A5.9 $2.52
12/30/20229,000,000 shares $20.34 million -1.6%N/A5.6 $2.26
12/15/20229,150,000 shares $24.71 million -44.4%N/A5.3 $2.70
11/30/202216,470,000 shares $46.12 million -1.9%N/A9 $2.80
11/15/202216,790,000 shares $65.82 million -3.2%N/A10.6 $3.92
10/31/202217,350,000 shares $65.24 million -0.2%N/A10.6 $3.76
10/15/202217,390,000 shares $61.73 million -0.6%N/A9.5 $3.55
9/30/202217,500,000 shares $56 million -0.5%N/A7.7 $3.20
9/15/202217,590,000 shares $64.38 million -0.2%N/A6.5 $3.66
8/31/202217,630,000 shares $69.46 million -6.5%N/A6.1 $3.94
8/15/202218,860,000 shares $92.60 million -0.7%N/A6.1 $4.91
7/31/202219,000,000 shares $75.24 million -19.4%N/A5.7 $3.96
7/15/202223,560,000 shares $84.34 million +17.1%N/A6.6 $3.58
6/30/202220,120,000 shares $76.46 million +14.1%N/A5.2 $3.80
6/15/202217,640,000 shares $59.27 million -1.2%N/A4.4 $3.36
5/31/202217,860,000 shares $62.15 million -1.3%N/A4.2 $3.48
5/15/202218,100,000 shares $72.22 million -1.3%N/A4.4 $3.99
4/30/202218,330,000 shares $75.70 million -10.3%N/A4.7 $4.13
4/15/202220,430,000 shares $125.85 million -2.3%N/A5.6 $6.16
3/31/202220,920,000 shares $112.76 million -12.1%N/A7 $5.39
3/15/202223,790,000 shares $106.58 million +11.5%N/A8.6 $4.48
2/28/202221,330,000 shares $218.42 million +3.6%N/A8.3 $10.24
2/15/202220,580,000 shares $230.08 million +4.7%11.4%8.2 $11.18
1/31/202219,660,000 shares $218.62 million +6.3%10.8%7.8 $11.12
1/15/202218,500,000 shares $223.85 million -2.5%10.2%7.6 $12.10
12/31/202118,980,000 shares $256.42 million +11.3%10.4%8.7 $13.51
12/15/202117,060,000 shares $221.10 million +5.7%9.4%8.4 $12.96
11/30/202116,140,000 shares $181.74 million -4.0%8.9%12.1 $11.26
11/15/202116,820,000 shares $224.38 million +3.2%9.2%14.9 $13.34
10/29/202116,300,000 shares $247.11 million +1.6%9.0%15.8 $15.16
10/15/202116,040,000 shares $277.65 million -0.9%8.8%18.7 $17.31
9/30/202116,190,000 shares $290.77 million -1.8%8.9%18.9 $17.96
9/15/202116,480,000 shares $266.65 million -5.0%9.1%19 $16.18
8/31/202117,350,000 shares $268.58 million -1.5%9.6%20.4 $15.48
8/13/202117,620,000 shares $251.79 million -2.0%9.7%20.9 $14.29
7/30/202117,970,000 shares $283.75 million +0.7%10.0%21 $15.79
7/15/202117,840,000 shares $295.97 million -1.8%9.9%19.8 $16.59
6/30/202118,160,000 shares $311.63 million -0.8%10.1%20 $17.16
6/15/202118,310,000 shares $325.00 million +1.5%10.2%20.8 $17.75
5/28/202118,040,000 shares $325.98 million -0.4%10.0%20.7 $18.07
5/14/202118,110,000 shares $341.55 million -5.9%N/A19.9 $18.86
4/30/202119,240,000 shares $386.53 million -2.2%N/A18.2 $20.09
4/15/202119,680,000 shares $376.68 million +2.1%N/A16 $19.14
3/31/202119,280,000 shares $376.15 million -3.3%N/A15.3 $19.51
3/15/202119,940,000 shares $455.03 million -6.2%N/A14.9 $22.82
2/26/202121,250,000 shares $476.85 million +0.4%N/A15.9 $22.44
2/12/202121,160,000 shares $481.39 million -7.6%N/A16.7 $22.75
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

1/29/202122,900,000 shares $422.28 million -4.5%N/A19.4 $18.44
1/15/202123,970,000 shares $426.67 million -1.0%N/A22.6 $17.80
12/31/202024,200,000 shares $434.15 million -1.5%N/A24 $17.94
12/15/202024,560,000 shares $433.24 million -0.3%N/A23.8 $17.64
11/30/202024,640,000 shares $413.71 million -0.2%N/A23.7 $16.79
11/15/202024,700,000 shares $426.57 million -2.1%N/A22.9 $17.27
10/30/202025,240,000 shares $409.14 million -2.5%N/A23.8 $16.21
10/15/202025,890,000 shares $454.11 million +1.7%N/A26.4 $17.54
9/30/202025,470,000 shares $422.55 million -1.3%N/A27.5 $16.59
9/15/202025,800,000 shares $516.26 million -1.7%N/A28.3 $20.01
8/31/202026,240,000 shares $507.48 million -0.7%N/A29 $19.34
8/14/202026,420,000 shares $516.51 million -1.3%N/A27.5 $19.55
7/31/202026,770,000 shares $593.22 million +0.1%N/A26 $22.16
7/15/202026,740,000 shares $630.80 million -2.3%N/A24.5 $23.59
6/30/202027,360,000 shares $613.41 million -1.2%N/A23 $22.42
6/15/202027,700,000 shares $567.57 million +3.3%N/A22.3 $20.49
5/29/202026,810,000 shares $595.45 million -3.3%N/A19.4 $22.21
5/15/202027,730,000 shares $610.61 million -1.3%N/A19 $22.02
4/30/202028,090,000 shares $539.33 million -0.9%N/A18.6 $19.20
4/15/202028,340,000 shares $521.46 million +2.5%N/A18.1 $18.40
3/31/202027,640,000 shares $541.74 million +0.8%N/A13 $19.60
3/13/202027,428,900 shares $515.11 million +1.3%N/A17.3 $18.78
2/28/202027,070,000 shares $435.01 million -2.3%N/A12.4 $16.07
2/14/202027,700,000 shares $498.05 million -3.5%16.0%11.7 $17.98
1/31/202028,690,000 shares $614.25 million -3.0%16.6%10.7 $21.41
1/15/202029,590,000 shares $662.82 million +0.7%17.1%10.7 $22.40
12/31/201929,390,000 shares $621.01 million -4.9%17.0%10.9 $21.13

NKTR Short Interest - Frequently Asked Questions

What is Nektar Therapeutics' current short interest?

Short interest is the volume of Nektar Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 5,230,000 shares of NKTR short. 2.94% of Nektar Therapeutics' shares are currently sold short. Learn More on Nektar Therapeutics' current short interest.

What is a good short interest ratio for Nektar Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NKTR shares currently have a short interest ratio of 4.0. Learn More on Nektar Therapeutics's short interest ratio.

What is a good short interest percentage for Nektar Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.94% of Nektar Therapeutics' floating shares are currently sold short.

Is Nektar Therapeutics' short interest increasing or decreasing?

Nektar Therapeutics saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 5,230,000 shares, a drop of 13.4% from the previous total of 6,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Nektar Therapeutics' float size?

Nektar Therapeutics currently has issued a total of 184,458,000 shares. Some of Nektar Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nektar Therapeutics currently has a public float of 177,810,000 shares.

How does Nektar Therapeutics' short interest compare to its competitors?

2.94% of Nektar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nektar Therapeutics: ADC Therapeutics SA (3.28%), Seres Therapeutics, Inc. (10.45%), Atea Pharmaceuticals, Inc. (3.50%), Omeros Co. (21.64%), Assembly Biosciences, Inc. (0.18%), Cumberland Pharmaceuticals Inc. (0.97%), Agios Pharmaceuticals, Inc. (7.85%), Alkermes plc (10.15%), Novo Nordisk A/S (0.13%), Eli Lilly and Company (0.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Nektar Therapeutics stock?

Short selling NKTR is an investing strategy that aims to generate trading profit from Nektar Therapeutics as its price is falling. NKTR shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Nektar Therapeutics?

A short squeeze for Nektar Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NKTR, which in turn drives the price of the stock up even further.

How often is Nektar Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NKTR, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:NKTR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners